Model Number 694958 |
Device Problems
Signal Artifact/Noise (1036); Over-Sensing (1438); Pocket Stimulation (1463); Under-Sensing (1661)
|
Patient Problem
Muscle Stimulation (1412)
|
Event Date 07/23/2018 |
Event Type
malfunction
|
Manufacturer Narrative
|
Concomitant medical products: w1tr01 ipg, implanted: (b)(6) 2017; 407652 lead, implanted: (b)(6) 2018.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
It was reported that the patient experienced pocket stimulation caused by the right ventricular (rv) lead.It was noted that the right ventricular (rv) lead had high bipolar impedance measurements, high threshold measurements and over-sensing with noise.It was also noted that the rv lead had t-wave over-sensing (twos) and possible far field r-wave (ffrw) of the right atrial (ra) lead.The rv lead and ra lead remain in use.No further patient complications have been reported as a result of this event.
|
|
Manufacturer Narrative
|
The initial reported event of the right ventricular (rv) lead had a polarity switch.Transmissions showed high rv bipolar impedance measurements, high rv threshold measurements, and over-sensing of the rv lead.The lead remains in use.No patient complications have been reported as a result of this event was submitted via an alternative summary report.As the summary report has been revoked, this new information is therefore being submitted via a 30-day report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Additional information received indicated the rv lead exhibited intermittent undersensing and additional oversensing noted although there is evidence of true arrhythmia at some points.The remote transmission also noted rv lead bipolar and unipolar impedance warnings noted as high undefined impedance and high sensing integrity counter (sic).The ra lead ffrw was observed and confirmed and a failed lead position checked was noted.
|
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Additional information received from following facility indicated the ra lead sensing and threshold was evaluated for failed position check and the lead was noted as functioning well.No action or intervention was taken on the ra lead and rv lead.
|
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|